![]() Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. | ![]() Oxurion Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. | ![]() ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. | |
Founding Date | Founding Date 1972 | Founding Date 1991 | Founding Date 1996 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Olaine, LV HQ | Locations Leuven, BE HQ Dublin 8, IE | Locations Baudette, US HQ Oakville, CA Baudette, US |
Employees | Employees 2,191 | Employees 785% increase | Employees 33813% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 626.1 k | Valuation ($) 1.2 b |
Financial | |||
Revenue (est.) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) €555k (FY, 2025) | Revenue (est.) $883.4m (FY, 2025) |
Cost of goods | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit €80.1m (FY, 2020) | Gross profit €937k (FY, 2025) | Gross profit N/A |
Net income | Net income €9.5m (FY, 2020) | Net income (€3.7m) (FY, 2025) | Net income N/A |

Oxurion (formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye.
View company
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View company